1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

ZBH.SW
Zimmer Biomet Holdings, Inc.CH flagSwiss Exchange
62.50
CHF
-2.50
- -
12.09BMarket Cap
Zimmer Biomet Holdings, Inc.
ZBH.SW
(Swiss Exchange)

Recent

price

62.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
23.73
25.57
27.26
- -
27.65
32.01
38.34
38.65
38.98
38.92
29.6
32.73
33.11
35.43
37.81
41.57
42.81
Revenue per Share
4.06
4.32
4.6
- -
4.26
0.78
1.53
8.98
-1.86
5.52
-0.67
1.93
1.1
4.91
4.45
3.56
3.87
Basic EPS, GAAP
5.57
5.93
5.09
- -
5.42
3.64
7.24
7.06
7.79
5.76
5.28
6.46
5.09
5.69
5.63
7.17
6.97
Free Cash Flow per Basic Share
- -
0.54
0.78
- -
0.86
0.84
0.94
0.96
0.96
0.96
0.96
0.96
0.96
0.96
0.97
0.96
0.96
Dividend per Share
34.27
40.53
45.49
- -
49.5
44.56
42.35
49.66
46.66
50.86
48.74
49.35
45.62
49.77
54.65
58.66
60.1
Book Value per Share
11.14
14.6
17.58
- -
20.32
-46.91
-48.8
-36.09
-29.5
-21.77
-19.89
-8.56
-7.71
-5.69
-5.28
-9.89
-9.15
Tangible Book Value per Share
188
175
170
169
169
187
200
202
204
205
207
209
210
209
203
198
196
Basic Weighted Avg Shares
4,452
4,472
4,623
- -
4,673
5,998
7,668
7,803
7,933
7,982
6,128
6,827
6,940
7,394
7,679
8,232
8,409
Sales/Revenue/Turnover
27.58
26.93
25.65
- -
24.99
15.51
17.7
18.08
14.46
15.91
11.5
14.73
17.18
19.63
19.9
16.48
16.8
Operating Margin (%)
360
363
358
- -
376
712
1,039
1,063
1,040
1,006
898
938
926
952
996
1,094
1,109
Depreciation Expense
761
755
780
- -
720
147
306
1,814
-379
1,132
-139
402
231
1,024
904
705
761
Net Income, GAAP
22.36
23.96
22.77
- -
23.44
4.57
23.77
- -
- -
- -
- -
10.72
27.83
3.95
12.68
15.13
15.76
Effective Tax Rate (%)
17.09
16.88
16.88
- -
15.41
2.45
3.99
23.24
-4.78
14.18
-2.27
5.88
3.33
13.85
11.77
8.57
9.05
Profit Margin (%)
2,410
2,843
3,166
- -
3,289
4,236
2,282
1,495
2,006
1,282
2,526
1,417
2,069
1,752
2,221
2,536
2,098
Working Capital
1,576
1,721
1,672
- -
1,426
11,497
10,666
8,918
8,414
6,721
7,626
5,464
5,152
4,868
5,342
6,932
6,295
LT Debt
5,515
5,866
6,300
- -
6,552
9,889
9,670
11,736
11,276
12,393
12,199
12,666
12,027
12,488
12,476
12,706
12,682
Total Equity
13.42
12.25
11.52
- -
22.19
6
4.85
- -
- -
- -
- -
4.48
4.6
7.76
7.25
5.95
5.99
Return on Invested Capital (%)
10.73
9.52
9.14
- -
15.72
2.84
2.92
- -
- -
- -
- -
3.3
2.14
7.74
6.53
5.23
5.36
Return on Capital (%)
12.54
11.17
10.54
- -
17.22
1.76
3.64
19.61
-3.89
11.36
-1.35
3.94
2.33
10.27
8.41
6.21
6.61
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
600
587
1,176
LT Borrowings
7,513
6,932
6,295
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
198
195
193
Market Capitalization
17,956
20,413
17,207

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
5,835
5,120
4,962
Cash, Cash Equivalents & STI
1,293
592
424
Accounts Receivable, Net
1,598
1,704
1,729
Inventories
2,484
2,286
2,247
Total Current Liabilities
2,403
2,584
2,864
Payables & Accruals
315
1,615
655
ST Debt
600
587
1,176
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.79%
0.87%
1.84%
Free Cash Flow
12.32%
6.87%
24.3%
Net Income, GAAP
-15.33%
-24.54%
-21.98%
Sales/Revenue/Turnover
3.93%
6.13%
7.2%
Total Cash Common Dividend
2.11%
-0.83%
-2.91%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,889
1,942
1,824
2,023
7,679
2025
1,909
2,077
2,001
2,244
8,232
2026
2,087
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.84
1.18
1.23
1.2
4.45
2025
0.92
0.77
- -
- -
3.56
2026
1.22
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.24
0.24
0.24
0.24
0.97
2025
0.24
0.24
- -
- -
0.96
2026
0.24
- -
- -
- -
- -
Similar Companies
ViewRay, Inc. (VRAYQ)
Motus GI Holdings, Inc. (MOTS)
Modular Medical, Inc. (MODD)
Respiri Limited (RSH.AX)
Longport, Inc. (LPTI)
Accuray Incorporated (ARAY)
Business
Zimmer Biomet Holdings, Inc. (NYSE: ZBH; SIX: ZBH.SW) designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities, and trauma products; spine products; dental reconstructive products; bone cement; and related surgical products, along with integrated digital and robotic technologies including AI-powered platforms that leverage data analytics across the patient journey. The company operates in more than 25 countries with sales in over 100 countries, targeting healthcare providers and patients in musculoskeletal care. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet recently completed the acquisition of Paragon 28 on April 21, 2025, for approximately $1.1 billion in equity value to expand its foot and ankle portfolio and accelerate growth in high-single-digit expanding markets including ambulatory surgery centers; acquired Monogram Technologies in October 2025 to broaden its orthopedic robotics and navigation offerings; and launched innovations such as the first fully autonomous orthopedic robot and an iodine-treated hip implant to combat periprosthetic joint infections, driving 5.6% organic U.S. revenue growth in Q3 2025 from its "Magnificent Seven" new products.

Company News

APIChatGPT

  • prnewswire.com

    Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

  • prnewswire.com

    Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference